VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
FATE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
FATEFate Therapeutics, Inc.
$3.02$352M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksFATEQuarterly Financials

Fate Therapeutics, Inc. (FATE) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Fate Therapeutics, Inc. (FATE) quarterly income statement — complete revenue, gross profit & net income history

FATE Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue1.3M1.37M1.74M1.91M1.63M1.86M3.07M6.77M1.93M1.68M1.94M933K58.98M44.36M14.98M18.55M18.41M17.07M14.22M13.41M
Revenue Growth %-20.26%-26.4%-43.36%-71.84%-15.38%10.98%58.13%625.83%-96.74%-96.22%-87.02%-94.97%220.3%159.86%5.31%38.3%65.27%7.38%88.21%145.42%
Cost of Goods Sold2.92M0000004.72M4.82M4.88M4.74M40.88M65.63M87.19M79.82M81.31M72.14M69.52M53.13M48.02M
COGS % of Revenue224.63%------69.71%250.44%291.47%243.83%4381.14%111.27%196.57%532.79%438.34%391.76%407.26%373.5%358.06%
Gross Profit-1.62M1.37M1.74M1.91M1.63M1.86M3.07M2.05M-2.9M-3.21M-2.8M-39.94M-6.65M-42.84M-64.84M-62.76M-53.73M-52.45M-38.91M-34.61M
Gross Margin %-124.63%100%100%100%100%100%100%30.29%-150.44%-191.47%-143.83%-4281.14%-11.27%-96.57%-432.79%-338.34%-291.76%-307.26%-273.5%-258.06%
Gross Profit Growth %-199.39%-26.4%-43.36%-7.02%156.25%157.96%209.94%105.13%56.44%92.51%95.69%36.35%87.62%18.33%-66.65%-81.32%-59.37%-127.18%-68.16%-63.23%
Operating Expenses31.38M36.09M36.48M38.88M42.91M63.61M55.45M47.13M48.17M44.87M48.48M22.62M21.94M21.58M21.55M20.35M20.74M16.94M15.72M12.17M
OpEx % of Revenue2415.78%2636.23%2095.12%2038.54%2634.07%3419.78%1803.87%696.01%2502.44%2676.97%2493.98%2424.65%37.2%48.66%143.88%109.71%112.64%99.22%110.5%90.72%
Selling, General & Admin9.6M10.66M10.64M11.45M13.77M15.26M20.8M17.25M20.86M17.93M18.95M22.62M21.94M21.58M21.55M20.35M20.74M16.94M15.72M12.17M
SG&A % of Revenue738.72%779.04%611.03%600.16%845.49%820.54%676.68%254.74%1083.38%1070.11%974.69%2424.65%37.2%48.66%143.88%109.71%112.64%99.22%110.5%90.72%
Research & Development21.79M25.43M25.84M27.43M29.14M33.61M34.65M34.6M32.14M31.82M34.27M40.88M65.63M87.19M79.82M81.31M72.14M69.52M53.13M48.02M
R&D % of Revenue1677.06%1857.2%1484.09%1438.38%1788.58%1806.94%1127.2%510.99%1669.51%1898.33%1763.12%4381.14%111.27%196.57%532.79%438.34%391.76%407.26%373.5%358.06%
Other Operating Expenses000001000K0-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income-33M-34.72M-34.73M-36.97M-41.28M-61.75M-52.38M-45.08M-51.07M-48.08M-51.28M-62.56M-28.59M-64.42M-86.39M-83.11M-74.47M-69.38M-54.62M-46.78M
Operating Margin %-2540.42%-2536.23%-1995.12%-1938.54%-2534.07%-3319.78%-1703.87%-665.73%-2652.88%-2868.44%-2637.81%-6705.79%-48.48%-145.23%-576.67%-448.05%-404.4%-406.48%-383.99%-348.78%
Operating Income Growth %20.06%43.77%33.68%18%19.17%-28.44%-2.14%27.94%-78.61%25.37%40.64%24.72%61.6%7.15%-58.16%-77.66%-61.15%-107.74%-73.48%-62.95%
EBITDA-30.08M-31.66M-31.51M-33.69M-37.95M-56.94M-47.77M-40.36M-46.25M-43.19M-46.54M-58.1M-24.4M-59.58M-83.2M-80.15M-71.71M-67.18M-53.1M-45.61M
EBITDA Margin %-2315.78%-2312.49%-1809.76%-1766.65%-2329.47%-3061.02%-1554%-596.01%-2402.44%-2576.97%-2393.98%-6227.12%-41.37%-134.32%-555.36%-432.08%-389.41%-393.56%-373.31%-340.09%
EBITDA Growth %20.73%44.4%34.04%16.53%17.95%-31.82%-2.65%30.53%-89.53%27.51%44.06%27.51%65.97%11.31%-56.67%-75.71%-58.46%-106.45%-72.9%-63.14%
D&A (Non-Cash Add-back)2.92M3.06M3.23M3.28M3.33M4.81M4.61M4.72M4.82M4.88M4.74M4.47M4.19M4.84M3.19M2.96M2.76M2.21M1.52M1.17M
EBIT-33M-34.72M-32.25M-34.07M-41.28M-47.01M-52.38M-45.08M-51.07M-48.08M-51.28M-62.56M-28.59M-64.42M-86.39M-83.11M-74.47M-69.38M-54.62M-46.78M
Net Interest Income1.87M2.22M2.58M2.92M3.34M3.87M4.44M4.83M4.15M4.41M4.7M4.38M3.69M2.88M1.79M757K418K297K289K346K
Interest Income1.87M2.22M2.58M2.92M3.34M3.87M4.44M4.83M4.15M4.41M4.7M4.38M3.69M2.88M1.79M757K418K297K289K346K
Interest Expense00000000000000000000
Other Income/Expense1.79M2.35M2.48M2.9M3.66M9.6M4.7M6.66M3.06M3.95M6.11M9.81M9.71M8.06M2.83M7M8.78M761K11.31M-8.35M
Pretax Income-31.21M-32.37M-32.25M-34.07M-37.62M-52.15M-47.68M-38.43M-48M-44.12M-45.17M-52.76M-18.88M-56.36M-83.56M-76.11M-65.69M-68.62M-43.31M-55.13M
Pretax Margin %-2402.85%-2364.79%-1852.38%-1786.58%-2309.45%-2803.92%-1551.01%-567.44%-2493.71%-2632.58%-2323.56%-5654.34%-32.01%-127.07%-557.79%-410.29%-356.74%-402.02%-304.45%-411.07%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-31.21M-32.37M-32.25M-34.07M-37.62M-52.15M-47.68M-38.43M-48M-44.12M-45.17M-52.76M-18.88M-56.36M-83.56M-76.11M-65.69M-68.62M-43.31M-55.13M
Net Margin %-2402.85%-2364.79%-1852.38%-1786.58%-2309.45%-2803.92%-1551.01%-567.44%-2493.71%-2632.58%-2323.56%-5654.34%-32.01%-127.07%-557.79%-410.29%-356.74%-402.02%-304.45%-411.07%
Net Income Growth %17.03%37.92%32.36%11.34%21.63%-18.2%-5.55%27.16%-154.25%21.72%45.95%30.68%71.26%17.86%-92.95%-38.04%-45.69%-29.2%26.2%-96.4%
Net Income (Continuing)-31.21M-32.37M-32.25M-34.07M-37.62M-52.15M-47.68M-38.43M-48M-44.12M-45.17M-52.76M-18.88M-56.36M-83.56M-76.11M-65.69M-68.62M-43.31M-55.13M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.26-0.27-0.27-0.29-0.32-0.44-0.40-0.33-0.47-0.45-0.46-0.54-0.09-0.50-0.83-0.79-0.59-0.72-0.45-0.58
EPS Growth %18.75%38.64%32.5%12.12%31.91%2.22%13.04%38.89%-402.67%10%44.58%31.65%84.15%30.56%-84.44%-36.21%-22.92%-18.03%33.82%-65.71%
EPS (Basic)-0.26-0.27-0.27-0.29-0.32-0.44-0.40-0.33-0.47-0.45-0.46-0.54-0.09-0.50-0.83-0.79-0.59-0.72-0.45-0.58
Diluted Shares Outstanding120.03M118.79M119M118.53M118.38M117.79M117.77M117.47M101.1M98.61M98.57M98.4M98.05M97.22M97.02M96.7M96.34M95.79M95.41M94.33M
Basic Shares Outstanding120.03M118.79M119M118.53M118.38M117.79M117.77M117.47M101.1M98.61M98.57M98.4M98.05M97.22M97.02M96.7M96.34M95.79M95.41M94.33M
Dividend Payout Ratio--------------------